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ABBREVIATIONS  
AGE   - Advanced glycation end products  
BP   - Blood pressure 
CT   - Computerised axial tomography  
DAG   - Diacylglycerol  
DM   - Diabetes mellitus  
EOM   - Extra ocular movements 
FBS   - Fasting blood sugar 
HbA1c / GHb  - Glycosylated haemoglobin A1c 
LPS   - Levator palpebrae superioris  
MRA   - Magnetic resonance angiography 
MRI    - Magnetic resonance imaging  
NAD    - Nicotinamide adenine dinucleotide  
NADP  - Nicotinamide adenine dinucleotide phosphate  
NADPH   - Reduced nicotinamide adenine dinucleotide  
    phosphate  
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PAI - 1   - Plasminogen activator inhibitor - 1 
PKC    - Protein kinase C  
PPBS   - Post prandial blood sugar 
RAGEs  - Receptors for advanced glycation end products 
ROS   - Reactive oxygen species  
TGF β1  - Transforming growth factor β1 
VDRL  - Venereal disease research laboratory  
VEGF  - Vascular endothelium derived growth factor 
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INTRODUCTION & HISTORY  
 A perfect alignment between the motor system of two eyes is 
responsible for viewing an object as single. The extraocular muscles of 
both eyes work in co-ordination. When any one or more of these falter, 
it may manifest as double vision, drooping of eyelids, deviation  of eyes 
or some times with pain. Patients may present to the ophthalmologist for 
one of these complaints, may be referred by another physician or be 
seen accidently while they come for a routine check up. This may be one 
of the first manifestation of a multisystem disease like diabetes mellitus.  
 The best early evidence of description of diabetes in world's  
literature is recorded in Ebers papyres dated 1550 BC. Arateus of 
Cappadocia coined the term 'diabetes', meaning, "siphon", to explain the 
liquefication of flesh and bone into urine.  
 In 400 B.C. Susrata, an Indian Surgeon had described the diabetic 
syndrome as characterised by a "honeyed urine".  
 Diabetic retinopathy was first described in 1869 by Eduard von 
Jauger, and specific lesions like – "Microaneurysms and new vessels" – 
were described by Stephan Mackenzie and Edward Nettleship in 1880. 
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 In 1964, Marchal de calvi associated neuropathy with diabetes 
and symptoms were clearly reported by Frederide Pavy in 1885. 
Albuminuria was noted as a common abnormality in diabetic patients by 
Joslin in 1916.  
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DEFINITION 
 Diabetes mellitus is defined as a group of metabolic diseases 
characterized by hyperglycaemia resulting from defects in insulin 
secretion, insulin action or both. The chronic hyperglycaemia is 
associated with long-term damage, dysfunction and failure of various 
organs, especially the eyes, kidneys, nerves, heart and blood vessels.  
CLASSIFICATION OF DIABETES MELLITUS 
Type 1 (β-cell destruction usually leading to absolute insulin 
deficiency)  
Autoimmune  
Idiopathic  
Type 2  
 Ranges from predominantly insulin - resistant with relative 
insulin deficiency to a predominantly insulin - secretory defect with or 
without insulin resistance.  
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Other specific types 
Genetic defects β - cell function  
Genetic defects of insulin action  
Diseases of exocrine pancreas 
Endocrinopathies 
Drug-induced or chemical - induced  
Infections  
Uncommon forms of immune mediated diabetes 
Other genetic syndromes sometimes associated with diabetes 
Gestational diabetes 
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BIOCHEMICAL MECHANISMS OF  
DIABETES TISSUE DAMAGE 
•  Chronic tissue damage in diabetes is generally related to the 
severity and duration of hyperglycemia. Other determinants of 
specific complications include genetic predisposition and 
hypertension. Tissue damage may continue to evolve even 
after hyperglycaemia has been improved (hyperglycaemic 
memory).  
•  Diabetes particularly affects tissues in which glucose uptake 
increases during hyperglycaemia, leading to raised 
intracellular glucose concentrations. High glucose levels may 
cause cumulative and progressive tissue damage through 
irreversible alterations of structural proteins and other long-
lived molecules, or (e.g. in the retina) through the summation 
of micro vascular occlusions.  
•  At cellular level, hyperglycaemia may damage tissues by 
enhanced glucose flux through the polyol pathway; formtion 
of advanced glycation end-products (AGEs); activation of 
protein kinase (PKC); and stimulation of the hexosamine 
pathway. All these mechanisms may stem ultimately from 
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overproduction of superoxide by mitochondria, which 
metabolize excess glucose.  
• The polyol pathway, whose rate-limiting enzyme is aldose 
reductase, reduces glucose and several other sugars  
(e.g. glucose to sorbitol). The pathway operates in tissues that 
express aldose reductase (e.g.  lens, retina, endothelium), 
particularly during hyperglycaemia. Cellular damage may 
result from enhanced production of glycating sugars  
(e.g. methylglyoxal) and thus AGE formation, and/or depletion 
of reduced glutathione (a scavenger of reactive oxygen 
species, ROSs), resulting in oxidative damage.  
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 The pathway is normally inactive, but becomes active when 
intracellular glucose levels rise.  
 
 
 
 
 
 
 
 
 
1. ↓ NADPH causes  
• Reduced  glutathione depletion 
• Oxidative damage 
2. ↑ NADH / NAD+ causes  
• Increase Triose phosphates (AGE formation)  
• PKC activation 
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 Consequences of increased glucose flux through polyol pathway 
include the generation of powerful glycating sugars (methylglyoxal, 
acetol and triose phosphates), enhanced oxidative damage and protein 
kinase C (PKC) activation.  
• AGEs are the irreversible products of proteins that react with 
glycating sugars such as 3 - deoxy glucosone, methylglyoxal 
and the relatively weak glucose. Covalent cross-linking and 
other changes damage structural proteins (e.g. collagen) and 
extracellular matrix components, while circulating AGE - 
modified proteins bind to specific receptors for advanced 
glycation endproducts (RAGEs) on macrophages and 
endothelial cells. Macrophages release proinflammatory 
cytokines, while endothelial cells express procoagulant and 
adhesion proteins that favour thrombosis and ultimately 
atheroma formation; endothelial expression of vascular 
endothelium-derived growth factor (VEGF) also increases 
vascular permeability.  
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Fig.  2:  
 Formation of reversible, early, non-enzymatic glycation products 
and of irreversible advanced glycation end products (AGEs). Through a 
complex series of chemical reactions, Amadori products can form 
families of imidazole based and pyrrole  - based glucose derived cross - 
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PKC insoforms (especially β and δ) are activated by diacyl 
glycerol (DAG), synthesized de-novo from increased intracellular 
glucose. This may decrease tissue blood flow (by inhibiting 
production of the potent vasodilator, nitric oxide) and enhance 
vascular permeability via increased VEGF expression. Induction 
of plasminogen activator inhibitor - 1 (PAI - 1) expression may 
favour thrombosis.  
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3 
 Activation of protein kinase - C by de-novo synthesis of 
diacylglycerol, following increased glucose utilization. 
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• High intracellular glucose levels result in increased 
production of glucosamine, which by leading to glycation of 
transcription factors (forming their O - Glc Nacylated 
derivatives) may enhance transcription of specific genes 
including PAI - 1 and transforming growth factor β1 (TGF-
β1). 
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Fig. 4  The Glucosamine pathway 
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• Excess mitochondrial production of the ROS, superoxide, 
may cause all the above abnormalities. Superoxide 
production via the tricarboxylic acid (TCA) cycle is 
increased by hyperglycaemia; consequences include 
stimulation of aldose reductase activity, enhanced formation 
of methylglyoxal and thus AGE, increased DAG synthesis 
and PKC activation, and hexosamine pathway overactivity. 
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OCULAR MANIFESTATIONS OF DIABETES MELLITUS 
S.No. STRUCTURE MANIFESTATIONS 
EXTRAOCULAR 
1. LIDS Ptosis, Xanthelasma chronic 
blepharitis Recurrent stye & chalazion
2. EXTRAOCULAR 
MUSCLES 
Mononeuropathy 
3. LACRIMAL 
APPARATUS 
Decreased tear secretion, increased 
tear glucose levels 
4. ORBIT Orbitorhinomucormycosis 
OCULAR 
1. CORNEA Corneal hypoaesthesia, Recurrent 
erosions, corneal abrasions, punctate 
keratopathy, neurotrophic keratitis  
2. IRIS AND PUPIL Rubeosis iridis, small pupil, 
neovascular glaucoma 
3. ANGLE 
STRUCTURES 
Open angle glaucoma, secondary 
glaucoma 
4. LENS Fluctuating myopia, snowflake 
cataract, senile cataract 
5. VITREOUS Posterior vitreous detachment, 
Asteroid bodies 
6. RETINA Diabetic Retinopathy, Lipaemia 
Retinalis, Decreased contrast 
sensitivity and colour vision 
7. OPTIC NERVE Anterior ischaemic optic neuropathy, 
optic atrophy 
 
These are the associated findings in diabetes. We can look for 
them, so that they aid in clinical diagnosis of ocular motor nerve palsies. 
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OCULOMOTOR NERVE 
ANATOMY 
 The  third cranial nerve is entirely motor in function. It supplies 
all the extraocular muscles of the eyeball except the lateral rectus and 
superior oblique. It also supplies the intraocular muscles namely the 
sphincter pupillae and the ciliary muscles.  
FUNCTIONAL COMPONENTS 
1. SOMATIC EFFERENT - concerned with movements of the 
eyeball.  
2. GENERAL VISCERAL EFFERENT (parasympathetic) - for 
accommodation and contraction of the pupil.  
3. GENERAL SOMATIC AFFERENT - for carrying proprioceptive 
impulses from the muscles supplied by the third nerve.  
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THE OCULOMOTOR NUCLEAR COMPLEX 
LOCATION 
 It is situated in the midbrain at the level of the superior colliculus 
in the ventromedial part of the central gray matter that surrounds the 
cerebral aqueduct.  
 It is a longitudinal column, 10 mm long extending above from the 
floor of the third ventricle and below it is related to the nucleus of the 
fourth nerve. There are two motor nuclei.  
 1. Main motor nucleus of large multipolar neurons 
 2. Accessory Edinger Westphal nucleus of small multipolar  
  neurons.  
The main motor nucleus has the following subnuclei: 
1. DORSOLATERAL NUCLEUS - supplies ipsilateral 
inferior rectus 
2. INTERMEDIATE NUCLEUS - supplies ipsilateral inferior 
oblique 
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3. VENTROMEDIAL NUCLEUS - supplies ipsilateral 
medial rectus 
4. PARAMEDIAL NUCLEUS - supplies contralateral 
superior rectus 
5. CAUDAL CENTRAL NUCLEUS - supplies bilateral 
levator palpebrae superioris.  
 The Edinger Westphal nucleus lies posterior to the main 
oculomotor nuclear mass. It consists of a median and two lateral parts. It 
gives rise to preganglionic parasympathetic fibres.  
CONNECTIONS OF THE NUCLEUS 
1. Cerebral cortex  
 - motor cortex of both sides through the corticonuclear tracts. 
 - Visual cortex through the superior colliculus.  
 - frontal eye field 
2. Nuclei of 4th, 6th and 8th cranial nerves through the medial 
longitudinal fasciculus.  
3. Pretectal nucleus of both sides 
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4. Vertical and torsional gaze centres 
5. Cerebellum through the vestibular nuclei.  
COURSE AND DISTRIBUTION 
It can be divided into four parts 
 1. The fascicular part 
 2. The basilar part 
 3. The intracavernous part 
 4. The intraorbital part 
THE FASCICULAR PART 
 It consist of efferent fibres that pass from the third nerve nucleus 
through the red nucleus and the medial and a small lateral root, which 
unite to from a flattened nerve, which then gets twisted bringing the 
inferior fibres superiorly and vice versa. Thus the nerve becomes a 
rounded cord. The nerve then passes between the posterior cerebral and 
superior cerebellar arteries. Then it runs forward in the interpreduncular 
cistern (running lateral and parallel to the posterior communicating 
artery) to reach the cavernous sinus.  
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THE INTRACAVERNOUS PART 
 The nerve enters the cavernous sinus by piercing the posterior 
part of its roof on the lateral side of the posterior clinoid process. It then 
descends on the lateral wall of the sinus, where it lies above the 
trochlear nerve. In the anterior part of the cavernous sinus, the nerve 
divides into superior and inferior divisions which enter the orbit through 
the middle part of the superior orbital fissure within the annulus of Zinn.  
THE INTRAORBITAL PART 
 In the orbit the smaller superior division ascends on the lateral 
side of the optic nerve and supplies the superior rectus and levator 
palpebrae superioris. The larger inferior division divides into three 
branches.  
 i. Nerve to medial rectus passes inferior to the optic nerve.  
ii. Nerve to inferior oblique (longest of the three branches)  
passes in between the inferior rectus and lateral rectus and 
supplies the oblique from its posterior border. It gives off 
the motor root to the ciliary ganglion.  
iii. Nerve to inferior rectus passes and enters the muscle on its 
upper aspect.  
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THE FEATURES OF THIRD NERVE PALSY 
 It may be complete or incomplete and it may be congenital or 
acquired.  
 1. Ptosis - due to paralysis of LPS.  
2. Deviation - eyeball is turned down, out and slightly intorted 
due to unopposed action of the lateral rectus and the 
superior oblique.  
3. Ocular movements - restriction of the following 
movements.  
i.  Adduction - due to paralysis of medial rectus.  
ii.  Elevation - due to paralysis of superior rectus and inferior 
  oblique.  
iii.  Depression - due to paralysis of inferior rectus  
iv.  Extortion - due to paralysis of inferior rectus and inferior  
  oblique.  
 4. Pupil - is fixed and dilated due to paralysis of sphincter  
  pupillae.  
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5. Accommodation - completely lost due to paralysis of 
ciliary   muscle.  
6. Crossed diplopia - appears on manually raising the eyelid, 
  which occurs due to paralytic divergent squint.  
7. Head posture - if the pupillary area is uncovered the head 
takes a posture consistent with the directions of actions of 
paralysed muscle i.e. head is turned to the opposite side, 
titled towards the same side and chin is slightly raised.  
PUPIL SPARING ISOLATED III NERVE PARESIS 
 The pupillomotor fibres of the III  nerve travel in the outer layers 
of the nerve and are therefore closer to the nutrient blood supply 
enveloping the nerve. The outer fibres are supplied by the pial plexus 
whereas the inner fibres are supplied by the vasa nervosum.  
 So this explains why the diabetics (where the vasa nervonum are 
affected) have pupillary sparing in 80% and similarly in any ischaemic 
vascular etiology. In contradiction when compressive lesions involve the 
III nerve the superficial fibres are affected resulting in pupillary 
involvement in 90%.  
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 Most patients with ischaemic III nerve paresis demonstrate 
improvement in motility measurements within one month or may have 
complete recovery by 3 months (maximum : 6 months).  
 Cranial imaging like MR scanning – MRI, MRA, Four vessel 
angiography and Lumbar puncture are recommended if: 
i. The pupil is involved i.e. dilates or becomes dilated in the 
initial 5 – 7 days after onset.  
ii. No significant improvement in 3 months.  
iii. The patient develops signs of aberrant regeneration of III 
nerve.  
iv. Other neurologic findings develop.  
ABERRANT REGENERATION OF III NERVE 
 This is seen after trauma and tumour compression of the III nerve, 
but never after an ischaemic III nerve paresis. If the patient is followed 
with a presumed diagnosis of ischaemic III nerve palsy and then 
develops signs of aberrant regeneration, then MR scanning and cerebral 
angiography are indicated. 
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TROCHLEAR NERVE 
 The trochlear nerve is entirely motor in function and supplies only 
the superior oblique muscle of the eyeball. 
PECULIARITIES 
- The only cranial nerve to arise from the dorsal aspect 
of the brain. 
 -  The only cranial nerve to cross completely to the  
other  side i.e. the trochlear nerve arises from the  
 contralateral nucleus. 
- The longest and thinnest of all cranial nerves. 
FUNCTIONAL COMPONENTS 
1. SOMATIC EFFERENT – concerned with the primary, 
secondary and tertiary actions of superior oblique. 
2. GENERAL SOMATIC AFFERENT – carries 
proprioceptive impulses from the superior oblique. The 
impulses are relayed to the mesencephalic nucleus of the 
trigeminal nerve. 
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NUCLEUS 
 Situated in the ventromedial part of the central gray matter of the 
midbrain at the level of inferior colliculus. It is continuous with the III 
nerve nuclear complex. It belongs to the somatic efferent column of 
nuclei. 
CONNECTIONS OF THE NUCLEUS 
1. Cerebral cortex 
i. Motor cortex – of both sides through the corticonuclear 
tracts. 
ii. Visual cortex – through the superior colliculus 
iii. Frontal eye fields. 
2. Nuclei of 3rd, 6th and 8th cranial nerves through the medial 
longitudinal  bundle. 
3. Superior colliculi through the descending  predorsal bundle. 
4. Vertical and torsional gaze centres. 
5. Cerebellum through the vestibular nuclei. 
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COURSE AND DISTRIBUTION 
It is divided into 
i. The fascicular part 
ii. The precavernous part 
iii. The intracavernous part 
iv. The intraorbital part 
THE FASCICULAR PART 
 It consists of efferent fibres which after leaving the nucleus, pass 
posteriorly around the aqueduct in the central gray matter and decussate 
completely in the anterior medullary velum. 
THE PRECAVERNOUS PART 
 The trochlear nerve trunk emerges from the superior medullary 
velum just below the inferior colliculus on the dorsal aspect of midbrain. 
It then winds round the superior cerebellar peduncle and the cerebral 
peduncle just above the pons. It runs beneath the free edge of the 
tentorium, and like the III nerve passes between the posterior cerebral 
and superior cerebellar arteries to appear ventrally lateral to cerebral 
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peduncle. It then pierces the dura on the posterior corner of the roof of 
the cavernous sinus to enter into it. 
THE INTRACAVERNOUS PART 
 In the cavernous sinus, the nerve runs forwards in its lateral wall 
lying below the III nerve and above the first division of the fifth cranial 
nerve. In the anterior part of the cavernous sinus, it rises, crosses over 
the III nerve and leaves the sinus to pass through the lateral part of the 
superior orbital fissure (where it passes superolateral to the annulus of 
Zinn and medial to the frontal nerve). 
THE INTRAORBITAL PART 
 After entering through the lateral part of the superior orbital 
fissure, the nerve passes medially above the origin of the LPS and ends 
by supplying the superior oblique on its orbital surface. 
 The number of fibres in the intraorbital part of the trochlear nerve 
are greater than its intracranial part. These extra fibres carrying the 
proprioceptive impulses from the superior oblique leave the trochlear 
nerve to join the ophthalmic division of fifth nerve in the cavernous 
sinus. 
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FEATURES OF IV NERVE PALSY 
1. Hyperdeviation due to weakness of superior oblique. This 
becomes more obvious when the head is titled towards ipsilateral 
shoulder (Park Bielchowsky head tilt test). 
2. Ocular movements – depression is limited in adduction. Intorsion 
is also limited. 
3. Diplopia – vertical diplopia occurs on looking down. 
4. Abnormal head posture – To avoid diplopia head adopts a posture 
such that the action of superior oblique is less needed i.e. face is 
slightly turned to opposite side, chin is depressed and head is 
titled towards the opposite side. 
PARK-BIELCHOWSKY'S THREE STEP TEST 
 The medial and lateral rectus muscles do not have a vertical 
action. Therefore hypertropia of paretic etiology is due to weakness of 
one or more of the following vertically acting muscles. If the 
hypertropia is due to weakness of only one of these eight muscles, 
answering the following three questions identifies the paretic muscle.  
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1. First step – which is the higher eye? 
a) If the patient has a right hypertropia then the weak muscle 
is either a depressor of the right eye (right inferior rectus / 
right superior oblique) or an elevator of the left eye (left 
superior rectus / left inferior oblique).  
b) If the patient has left hypertropia then the weak muscle is 
either an elevator of the right eye (right superior rectus / 
right inferior oblique)  or depressor of the left eye (left 
inferior rectus are left superior oblique).  
2.  Second step –  hypertropia worse on right or left gaze?  
- The vertical rectus muscles (superior and inferior recti) 
have their greatest vertical action (and least torsional 
action) when the eye is abducted. The oblique muscles 
(superior and inferior obliques) have their greatest vertical 
action (and least torsional action) when the eye is adducted.  
 So in each case.  
i. Right hypertropia worse on right gaze (right inferior rectus 
/ left inferior oblique).  
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ii. Right hypertropia on left gaze (right superior oblique / left 
 superior rectus). 
iii. Left hypertropia worse on right gaze (left superior oblique / 
right superior rectus).  
iv. Left hypertropia worse on left gaze (right inferior oblique / 
left inferior rectus).  
3. Third step – Is the hypertropia worse on head tilt to right or left?  
a. The superior muscles (superior rectus and superior oblique) 
intort the eye; the inferior muscles (inferior rectus and 
inferior  oblique) extort the eye.  
b. When the head is titled to the right, right eye will be 
intorted by the contraction of the right superior rectus and 
right superior oblique; these two muscles work together in 
effecting the intorsion and neutralize each other's vertical 
action (right superior rectus is an elevator and right 
superior oblique is a depressor).  
c. If one of these muscles is the paretic muscle responsible for 
the hypertropia, then the vertical action will not be 
neutralized and the hypertropia will be worse on tilting the 
head to the right shoulder.  
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ABDUCENT NERVE 
It is an entirely motor nerve that supplies the lateral rectus 
muscles of the eyeball. 
FUNCTIONAL COMPONENTS 
i. SOMATIC EFFERENT – for lateral movement of the eye. 
ii. GENERAL SOMATIC AFFERENT for proprioceptive 
impulses from the lateral rectus muscle. These impulses 
ultimately reach the mesencephalic nucleus of the 
trigeminal nerve. 
NUCLEUS 
 Situated in the lower part of pons, close to the midline beneath the 
floor of the IV ventricle. It is closely related to the fasciculus of the 
facial nerve. It consists of two types of multipolar cells-large and small. 
The large multipolar cells give rise to fibres of the abducent nerve, while 
the fibres of the small multipolar cells relay in the oculomotor  nucleus 
via the medial longitudinal fasciculus. The small multipolar cells are 
believed to form the paraabducent nucleus. Since the abducent nucleus 
belongs to the group of somatic efferent nuclei, it lies in line with the 
nuclei of IV and III nerves above and the hypoglossal nucleus below. 
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CONNECTIONS OF THE NUCLEUS 
1. Cerebral cortex 
i. Motor cortex (precentral gyrus)  through the afferent 
corticonuclear fibres from both cerebral hemispheres. 
ii. Visual cortex, through the superior colliculus. 
iii. Frontal eye fields 
2. Nuclei of III, IV and VIII cranial nerves through the medial 
longitudinal bundle. 
3. Pretectal nucleus of both sides. 
4. Horizontal gaze centre through the medial longitudinal bundle. 
5. Cerebellum through vestibular nuclei. 
COURSE AND DISTRIBUTION 
 It is divided into 
i. The fascicular part 
ii. The basilar part 
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iii. The intracavernous part and 
iv. The intraorbital part. 
THE FASCICULAR PART 
 It consists of efferent fibres which start from the nucleus, pass 
forward traversing the medial lemniscus and the pyramidal tract. These 
then emerge by 7-8 rootlets from the junction of pons and medulla just 
lateral to the pyramidal prominence of medulla. The rootlets join to form 
one nerve, at varying distances from the origin. 
THE BASILAR PART 
 The nerve then runs forwards, upwards and slightly laterally 
through the cisterna pontis between the pons and the clivus. The nerve 
then runs upwards on the back of petrous temporal bone near its apex. 
At the sharp upper border of the petrous bone, the nerve bends forward 
at right angles under the petrosphenoidal ligament through the Dorello's 
canal and enters the cavernous sinus by piercing its posterior wall at a 
point lateral to the dorsum sellae and superior to the apex of petrous 
temporal bone. 
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THE INTRACAVERNOUS PART 
 In the cavernous sinus, the nerve runs horizontally forward, 
occupying a position below and lateral to the internal carotid artery. The 
internal carotid artery is surrounded by the sympathetic plexus. The 
nerve then leaves the cavernous sinus to enter the orbit through the 
middle part of the superior orbital fissure through the annulus of Zinn. 
In the superior orbital fissure, the abducent nerve lies inferolateral to the 
oculomotor and nasociliary nerves. 
THE INTRAORBITAL PART 
 In the orbit the nerve runs forwards and enters the ocular surface 
of the lateral rectus muscle just behind its middle portion after dividing 
into three or four branches. 
CLINICAL FEATURES OF SIXTH NERVE PALSY 
1. Deviation – In the primary position, the eyeball in convergent due 
to unopposed action of the medial rectus muscle. 
2. Ocular movements – Abduction is restricted. 
3. Diplopia – Uncrossed horizontal diplopia occurs, worse towards 
the action of the paralysed muscle. 
4. Head posture – The face is turned towards the action of the 
paralysed muscle to minimize diplopia. 
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FEATURES OF OCULAR MOTOR NERVE  
PALSIES IN DIABETES 
 
- III nerve commonly affected 
- More common in elderly 
- Pupillary sparing 
Because the peripherally situated pupillary fibres supplied by the 
pial plexus are spared whereas the centrally located fibres supplied by 
vasa  nervonum are affected. 
- Usually recover spontaneously and completely in months. 
- Can manifest as multiple episodes of transient ophthalmoplegia 
affecting different muscles of either one or both eyes. 
- Ocular motor nerve palsies in diabetes can be painless or painful 
DIFFERENTIAL DIAGNOSIS OF PAIN LESS 
OPHTHALMOPLEGIA 
Diabetes 
Hypertension 
Atherosclerosis 
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Weber's syndrome 
Tumours of orbit  
DIFFERENTIAL DIAGNOSIS OF PAINFUL 
OPHTHALMOPLEGIA  
Cavernous sinus thrombosis 
Tolosa Hunt syndrome 
Mucormyosis 
Nasopharyngeal carcinoma 
Herpes Zoster 
Lymphoma 
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TREATMENT OF OCULAR MOTOR NERVE PALSIES 
 
Management of Diabetes mellitus mainly consists of  
1. Life style modification  
2. Tight glycemic control with insulin  
 Follow up of cases of ocular motor nerve palsy that do not need 
urgent management, like the posterior communicating artery aneurysm 
must be at 6 weekly intervals till 6 months or till two consecutive 6 
weeks follow-ups reveal no change in motility. Every time diplopia 
charting, Hess charting, recording of deviations in nine gazes is done. 
During the meantime, patient is greatly disturbed by diplopia. So some 
nonsurgical modalities are practiced for symptomatic relief. It no 
resolution occurs after about 8-12 months then surgery is considered. 
1. Prisms  - are helpful in providing binocular vision as well as 
reducing the changes of development of contracture, but are 
useful only in small angle squints. Fresnel prisms are also 
used. 
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2. Botulinum toxin – the ipsilateral antagonist is paralysed by 
chemodenervation. The effect lasts for about 2-3 months. If 
necessary the injection can be repeated. 
3. Occlusive prisms or opaque contact lens. 
4. Surgery – mainly to weaken the antagonist, usually ipsilateral 
and sometimes also the contralateral antagonist, in addition to 
strengthening the paralysed muscle. The amount of recession 
resection varies depending upon which eye habitually fixates 
(secondary deviation or primary deviation needs to be 
corrected). Another principle is to restrain the contralateral 
antagonist by performing retroequatorial myopexy. 
In the case of III nerve, the aim is to achieve diplopia free ocular 
position in primary position and downgaze. The latter should never be 
compromised for the upgaze. Anyway it is difficult because the III nerve 
supplies most of the extraocular muscles except two. Moreover aberrant 
regenerations alter the clinical picture. Each case has to be considered 
on an individual basis. 
In the case of IV nerve, either strengthening of superior oblique or 
weakening of ipsilateral inferior oblique or contralateral inferior rectus 
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is done. The results of surgery for both congenital and acquired IV nerve 
palsy is excellent. 
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AIM OF THE STUDY 
1. To study the ocular motor nerve palsy pattern due to Diabetes 
Mellitus 
2. To study the relationship of glycaemic control in ocular motor 
nerve palsies. 
3. To study the association of diabetic retinopathy and nephropathy 
in case of ocular motor nerve palsies. 
4. To study the recovery pattern. 
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MATERIALS AND METHODS 
 The cases studied, included those patients with neurogenic ocular 
motor nerve palsies who presented to the Regional Institute of Ophthal-
mology and Govt. Ophthalmic Hospital. All age groups and both sexes 
were included.  
 A complete ophthalmological workup was done. 
INCLUSION CRITERIA 
1. All infranuclear ocular motor nerve palsies with DM 
EXCLUSION CRITERIA 
 All supranuclear, nuclear nerve palsies, myogenic and restrictive 
neuropathies. Associated combined condition like heart disease, were 
excluded. 
REGISTRATION 
 Name 
 Age 
 Sex 
Occupation 
Address 
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HISTORY OF PRESENT ILLNESS 
 The common complaints were: 
a. Double vision-whether uniocular/binocular, constant/  
intermittent, fluctuating or not, more for near or distance, 
whether images were horizontally or vertically separated, 
whether it is increased on any particular direction, onset 
and progress. 
b. Pain-headache/preiorbital pain, location, nature, any 
radiation, aggravating and relieving factors, any association 
with nausea/vomiting. 
c. Drooping of lids – unilateral/bilateral, total / partial 
d. Defective vision – apart from double vision, any blurring or 
inability to see due to drooping of lid. 
e. Deviation of eyeball-right/left, eye, duration 
f. Abnormal head posture 
g. Vertigo (sensation of rotation of self/surroundings) 
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Details of the progress from onset, the treatment undergone to the 
present state is noted. Any other significant medical/surgical history is 
also recorded. 
PAST HISTORY 
 H/o diabetes, hypertension, tuberculosis, syphilis, AIDS, 
malignancy in the present or past. 
 H/o migraine or neurologic disease 
 H/o xanthems and vaccination 
PERSONAL HISTORY 
 Diabetes, smoking, alcoholism etc. 
GENERAL EXAMINATION 
 General vital data like pulse, blood pressure, peripheral pulses are 
noted. Also gives an idea of the health status of the patients. 
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OCULAR EXAMINATION 
• Head posture, facial symmetry are noted. 
• Any deviation of eyeball is recorded. Under slit lamp, details of 
the anterior segment from the lids to the lens are noted. 
• Extraocular movements are noted down-both ductions and 
versions. While looking for EOM, the aberrant innervation 
patterns are also looked for. 
• Pupil size, reaction, any anisocoria is noted. 
• A dilated fundus examination and refraction is done. Ptosis and 
proptosis if present are evaluated. 
• Diplopia charting – is done in a dark room. Patient is asked to 
wear goggles with red in front of the right eye and green before 
the left eye. A torch light with a stenopaeic slit is used. The 
patient is asked to look at the torch held 120 cm away and then 
the torch is moved to various positions. The patient is asked to 
describe the position of the images. The false image is usually the 
fainter and farther one. Any tilt of the image and variation in the 
distance between images at various position is asked for. 
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• If a superior oblique palsy is suspected, Parks Bielchowsky's 3 
step head tilt test is done. 
• A forced duction test is performed in doubtful cases to rule out 
restrictive etiology. 
• Tensilon test is performed in some cases to rule out myasthenia 
gravis. 
NEUROLOGIC EXAMINATION 
 Examination of other cranial nerves 
 Motor, sensory, cerebellar symptoms and signs. 
EXAMINATION OF THYROID 
 Any neck swelling is looked for 
EXAMINATION OF SPINE & BACK 
 To look for congenital anomalies and neurocutanous markers. 
EXAMINATION OF ENT STRUCTURE 
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INVESTIGATIONS 
 Both right and left eye (for all cases) 
1. Vision a.  Uncorrected (Using Snellen's charts at 6  
    metres) 
   b.  Best corrected 
2. Intraocular pressure–with applanation tonometer after topical 
anaesthesia 
3. Detailed slit lamp examination 
 Lid 
 Conjunctiva 
 Cornea 
 Iris 
 Pupil 
 Anterior Chamber 
 Lens/Pseudophakia/Aphakia 
 53
4. Fundus examination-any abnormalities, diabetic retinopathy etc. 
5. Diplopia charting 
6. Park 3 step test 
7. Measurement of deviation-primary & secondary deviation, cover 
uncover test in various gaze positions, for near and distance as 
well. 
8. Hess charting 
9. Exophthalmometry 
10. Visual field examination 
BLOOD TEST : (For all cases) 
 Total count 
 Differential count 
 Erythrocyte sedimentation rate 
 Blood sugar  – Fasting 
    Postprandial 
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 In doubtful cases, Glucose tolerance test/Hb A1c 
 Mantoux intradermal test 
 Serum cholesterol 
 Blood VDRL 
 Rheumatoid factor 
RADIOLOGY (in indicated cases) 
 X ray orbit – fractures/erosions 
 X ray skull 
 X ray orbit – fractures/erosion 
 X ray skull 
 X ray chest – tuberculosis 
 X ray PNS – (paranasal sinuses) – mucococle, antral growth, 
sinusitis, orbit floor fractures. 
ORBITAL USG – (in indicated cases) 
NEURO IMAGING: (in indicated cases) 
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 CT 
 MRI 
 MRA 
 Cerebral angiography 
 Specialist opinion (in indicated cases) 
  Diabetologist 
  Otorhinolaryngologist 
  Neurophysician/Neurosurgeon 
  Radiologist 
FOLLOW UP 
 Recording of patient's complaints-whether stable/improving 
worsening. 
- Vision 
- Pupil assessment 
- Extraocular movements 
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- Diplopia charting 
- Fundus 
- Examining for signs of pupillary involvement or aberrant 
regeneration in cases of III N palsy 
- Investigations 
Blood sugar FBS 
  PPBS 
Hb A1c 
BP 
Imaging studies, if necessary. 
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RESULTS 
 51 cases of diabetic ocular motor nerve palsies were examined.  
A prospective study was conducted. 
1. AGE DISTRIBUTION 
 The following table shows the age distribution in the various 
ocular motor nerves affected due to diabetes. 
TABLE – I  
Age group 
III  
Nerve 
IV  
Nerve 
VI  
Nerve 
Multiple 
Nerves 
Total 
21-30 0 0 1 0 1 
31-40 1 0 3 0 4 
41-50 1 0 7 1 9 
51-60 12 0 17 0 29 
61-70 4 0 4 0 8 
     51 
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 In the study of 51 patients, the patients affected with sixth nerve 
palsy were maximal (62.74%) followed by III nerve palsy (35.29%) and 
the least in frequency were multiple ocular motor nerve palsy  
(1.96%). There was were no patient with fourth nerve involvement.  
 Regarding the age distribution, considering all the nerve palsies in 
total, the maximum number of patients belonged to 51-60 years age 
group (56.86%) followed in frequency by 41-50 years age group with 
17.6% of patients, 61-70 years age group with 15.68% patients and 31-
40 years age group with 7.84% patients. The least number was seen in 
the age group of 20-30 years (1.96%). 
 Considering each nerve palsy, with regard to third nerve, the 
maximum number was in the age group of 51-60 years  (23.52%) and 
followed in frequency by the age group of 61-70 years (7.84%).  
 With regard to sixth nerve palsy the maximum number was in the 
age group of 51-60 years. (33.33%) followed by 41-50 years age group 
(13.7%). 
 Multiple cranial ocular motor nerves were affected in one patients 
of the age group 41-50 years. 
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2. SEX DISTRIBUTION 
TABLE - II 
Nerve Male Female Total 
III 7 11 18 
IV 21 11 32 
Multiple 1 0 1 
Total 29 22 51 
 
 In the study there was a slight gender difference, with males  out 
numbering females – 56.8% males against  43.13% females. The 
incidence of III nerve palsy was higher in the females (21.56%) 
compared to males (13.7%). With regard to VI nerve palsy, the 
incidence was higher among males (41.17%) compared to female 
(21.56%). The patient with multiple nerve palsy was a male patients. 
The ratio of III nerve to  
VI nerve involvement among males was 1:3 where as in female it  
was 1:1. 
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3. LATERALITY 
TABLE - III 
Nerve Right Left 
III 7 11 
VI 13 19 
Multiple 0 1 
Total 20 31 
 
 Left eye involvement was common, with 31 out of 51 patients 
presenting with left side nerve palsy (60.70%). 19 patients of sixth nerve 
palsy and 11 patient with third nerve palsy were left sided. Multiple 
cranial nerve palsy patients was affected in the left side. Laterality 
difference was not statistically significant. 
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4.  GLYCAEMIC CONTROL AND MICROVASCULAR 
 COMPLICATIONS IN III NERVE PALSY  
TABLE - IV 
HbA1c% III Nerve Urine – Alb Retinopathy 
<6 1 0 1 
6.1 – 8.0 8 0 2 
8.1 – 10.0 8 2 5 
> 10  1 1 1 
 
In this study at the time of presentation of the patient to our 
hospital the glycaemic control was assessed by glycosylated 
haemaglobin levels. The table shows the incidence of nerve palsy along 
with the microvascular complications as assessed by urine macro 
albuminuria for diabetic nephropathy and the retinopathy status assessed 
by fundus examination. The glycosylated haemaglobin level gives the 
glycaemic status of the patient during the last three months. 
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It was observed that, with regard to III nerve palsy with HbA1C 
less than  6, one patient developed retinopathy. In the group of 8 patients 
with HbA1C 6.1-8.0 two had retinopathy (25%). With HbA1c between 
8.1-10, 5 of 8 patients had retinopathy (62.5%) where as 2 had 
nephropathy (25%) Only one patient had HbAIC > 10 and had both 
nephropathy and retinopathy (100%). 
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5. GLYCAEMIC CONTROL AND MICROVASCULAR 
COMPLICATIONS IN VI NERVE PALSY  
TABLE - V 
HbA1c% VI Nerve Urine – Alb Retinopathy
<6 1 0 0 
6.1 – 8.0 19 3 6 
8.1 – 10.0 7 0 3 
> 10  1 1 1 
 
With regard to VI nerve palsy, patients with HbAIC less than six 
showed no nephropathy or retinopathy. In the group of 19 patients with 
HbAIC between 6.1-8.0, six patient had retinopathy (31.57%), and 3 
patients had nephropathy (15.78%). 
7 patients had HbAIC between 8.1-10.0 and of these 3 had 
retinopathy (42.85%) and none had nephropathy. Only one patient 
presented with HbAIC of more than 10.0%, and had nephropathy (100%) 
and retinopathy (100%) both. 
One patient with multiple palsy i.e. III & VI nerve involvement 
had HbA1C of 9% and showed presence of both retinopathy and 
nephropathy.  
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6. RECOVERY PATTERN 
TABLE - VI 
Recovery III VI Multiple Total 
Full 10 20 0 30 
Partial 3 7 1 11 
No Recovery 1 2 0 3 
Lost follow up 4 3 0 7 
 
 The recovery pattern of the ocular motor nerve palsy due to 
Diabetes. Mellitus was varied. The recovery was noted when the 
patients came for follow up. Follow up was done at 2-3 weekly intervals 
for 3-4 months.  
 Few cases (ie. 7 patients) were lost to follow up during their 
reference to diabetology department and department of neuromedicine. 
So the recovery could not be documented in these patients. The recovery 
was noted in 4 months in most cases, which was almost complete in 6 
months. 
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DISCUSSION 
1. AGE 
 In this study 51 cases of Diabetes mellitus with ocular motor 
nerve palsies were examined. The widest range was associated with 
sixth nerve palsies in the present series. The majority of patients with 
either III nerve (23.52%) or VI nerve palsy (33.33%) belonged to 51-60 
years age group. In a study of 22 cases of III nerve palsy by Jack. E 
Goldstein and David G. Cogan the average age was 62 years. The sixth 
nerve was the commonly affected nerve in this study. Whereas, in 
literature the third nerve palsy is the most commonly affected followed 
by the sixth and seventh nerve. And in the third nerve palsy the pupil is 
usually spared. Cause is thought to be vascular with a localized infarct 
involving the brain stem nuclei or the emerging nerve root. Older people 
are mainly affected.  
2. SEX 
 In this study there was an overall slight gender difference with 
male preponderance 56.86% males compared to 43.13% females. 
Incidence of third nerve palsy was observed to be higher in females 
(21.56%)  compared to males (13.7%) whereas incidence of sixth nerve 
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palsy was more among males (41.17%) compared to females (21.56%). 
The patient with multiple nerve palsy was a male patient. The ratio of III 
nerve to sixth nerve involvement among males was 1:3. Whereas in 
females it was 1:1. 
 In our series the male to female ratio for incidence of III nerve 
palsy was 1:1.57 and for sixth nerve palsy it was 1.9:1. Comparing with 
the study by Goldstein and Cogan for third nerve palsy where male to 
female ratio was 1:1. 
3. LATERALITY 
 In the present series left eye involvement was found to be 
common (60.78%) 37.25% patients had sixth nerve palsy, 21.56% 
patients had third nerve palsy and 1.96% was multiple cranial nerve 
palsy. Bilaterality was not found in our series. The laterality does not 
seem to have a significance comparing with the study of Goldstein & 
Cogan where right & left eye were equally affected. There was a left eye 
preponderance in our study. 
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4.  GLYCAEMIC CONTROL AND MICROVASCULAR 
COMPLICATIONS IN III NERVE PALSY  
 Glycosylated Haemoglobin was taken to assess the overall 
glycaemic control of the patient at the time of incidence of the specific 
cranial nerve palsy. There is a large body of evidence that Glycated 
Haemoglobin relates to integrated preceding glycemic control. It is now 
recognised that Glycated Haemoglobin is the weighted measure of 
preceding glyceamia with recent events contributing more than distant 
ones.  
 Because of the link established by the DCCT and UKPDS 
between control as measured by HbA1c and microvascular 
complications, the magnitude of the HbA1c percentage can be regarded 
as a risk factor for the development of microangiopathy.  
 The American Diabetes Association recommends the goal of 
diabetes therapy should be an HbA1c of < 7%.  
 In our study only one patient was seen with third nerve palsy with 
HbA1c of less than 6%. This implies overall good glycaemic control in 
the past three months but this patient had mild non proliferative diabetic 
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retinopathy which may be explained by the duration of diabetes being 
more than 12 years.  
 There were 8 patients  with HbA1c between 6.1% to 8.0% of 
whom 25% had retinopathy and none had nephropathy. In the group 
with HbA1c between 8.1 to 10.%, there were 8 patients, of whom 62.5% 
had retinopathy and 25% had nephropathy.  
Only one patient in this series had HbA1c of more than 10% and 
she had both nephropathy and retinopathy. This implies that the patients 
with poorer control indicated by higher HbA1c had higher insidence of 
microvascular complications like nephropathy and retinopathy but there 
was no correlation between HbA1c and ocular motor  cranial nerve 
palsies.  
5.  GLYCAEMIC CONTROL AND MICROVASCULAR 
COMPLICATIONS IN VI NERVE PALSY  
 With regard to VI nerve only one patient had HbA1c less than 6% 
and had no evidence of retinopathy or nephropathy. This patient had 
diabetes for 2 years.  
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 In the group with HbA1c between 6.1% to 8.0% there were 19 
patients of whom retinopathy was found in 6 patients (31.8%) and 3 
patients had nephropathy (15.78%).  
 When glycated haemoglobin was in the range of 8.1 to 10%,  
7  patients had VI nerve palsy with 3 patients having retinopathy 
(42.85%) and none had nephropathy. The only patient with HbA1c of  
more than 10% had both nephropathy and retinopathy. The sole patient 
with multiple palsy had HbA1c level of 9% with both microvascular 
complication (i.e. retinopathy and nephropathy) This again went in for 
favour to imply that glyceamic control did not relate to oculor motor 
cranial nerve palsies.  
6. RECOVERY PATTERN 
 30 patients (58.8%) showed full recovery of whom 10 had III 
nerve palsy (55.5%) and 20 had VI nerve palsy (62.5%). 
 Partial recovery in the series was seen in 21.5% patients of whom  
3 suffered with III nerve palsy (16.6%) and 7 with VI nerve palsy 
(21.87%).  
 No recovery was seen in 5.88% of total patients of whom one 
belonged to III nerve palsy (5.55%) and 2 with VI nerve palsy (6.25%). 
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7 patients were lost to follow up. Patients who showed no recovery by 
the end of 6 months were further evaluated. In the series recovery 
pattern was found to be good with more than three fourth of the patients 
recovering fully or partially. 
 71
CONCLUSION 
1. The diabetic ocular motor nerve palsies occur in a wide range of 
age but are more common in the age group of 51 - 60 years.  
2. Overall males were affected more than females except in third 
nerve palsy which showed a slight female preponderance.  
3. Left eye involvement was common but was of no significance.  
4. Sixth nerve palsy was more common than third nerve palsy.  
5. Fourth nerve involvement in diabetes mellitus is comparatively 
rare & no patients were detected  with IV nerve palsy. 
6. There was no significant correlation between the level of 
glycaemic control and incidence of ocular motor nerve palsy 
though retinopathy and nephropathy were seen to occur more with 
poorer glycaemic status.  
7. More than three fourth of the patients had complete or partial 
recovery.  
8. A careful history, general and complete ophthalmological workup 
with necessary basic investigations is enough to diagnose patients 
with diabetic ocular motor nerve palsies. Further evaluation and 
specialist opinion are necessary when there is deviation from the 
normal pattern of recovery. 
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PROFORMA 
Name  : 
 
Age  : 
 
Sex  : 
 
Occupation  : 
 
Address : 
 
Date  :  Clinic No.    Hospital No.  
 
Complaints  : 
 
 
History:  
 
1. Visual complaints   
 
2. Diplopia, Headache  
 
3. Nausea 
 
4. Vomiting 
 
5. Consciousness  
 
6. Gait  
 
7. Sphincteric control  
 
8. Weakness 
 
9. Injury 
 
10. Personality disturbances 
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Examination 
Visual Acuity  :       
 
Right Eye Left Eye 
 VA 
UA 
Sph Cyl Axis VA VA 
UA 
Sph Cyl Axis VA 
DV           
NV           
 
Head position  : Head tilt / Face turn / Chin / Other skull 
     abnormalities 
Eyelids    : Ptosis, Retraction, Lidlag, Marcus Gunn 
     Phenomenon  
Eye Position   : Deviation / Proptosis  
Movements    : Uniocular & binocular, conjugate or  
   disconjugate  
Nystagmus   :  
 Right Eye Left Eye 
Pupils:   
Fundus:   
Tension:   
Fields:   
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Central Nervous System  
Higher Functions: 
 Right Eye Left Eye 
Crainal Nerves:  
(1,2,5,7,8,9,10,11,12 & 3,4,6) 
  
Motor System: Tone, Power, 
Wasting, Involuntary movements  
  
Sensory system: Touch, Pain, 
Temperature, Position & vibration  
  
Cerebellar System: Co-ordination, 
Tandem Walking 
  
Reflexes :   
 
Hess Screening, Diplopia Charting (Separate Charts Attached) 
Lab Investigations  
Blood Routine  
TC  
DC   
ESR         
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X - Ray No & Date 
Blood Sugar fasting and post prandial  
Urine Routine  
Mantoux 
VDRL  
Special Investigations : (CT, MRI) 
Treatment:  
Follow up:  
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KEY TO MASTER CHART 
 
LE: Left Eye 
RE: Right Eye 
NAD: No Abnormal Diagnosis 
Mild NPDR: Mild Non Proliferative Diabetic Retinopathy 
Mod NPDR: Moderate Non Proliferative Diabetic Retinopathy 
HTR: Hypertensive Retinopathy 
POST PRP: Post Pan Retinal Photocoagulation 
N: Negative 
P: Positive 
FBS: Fasting Blood Sugar  
PPBS: Postprandial Blood Sugar 
Hb1Ac: Glycated haemoglobin 
 
 
 
 
LIST OF SURGERIES PERFORMED 
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S. 
No 
NAME AGE/ 
SEX 
IP NO DIAGNOSIS PROCEDURE 
1. Sivaprakasam 65/M 382619 RE – IMC  RE-SICS/PCIOL 
2. Leelavathy  67/F 382759 BE–IMC L>R RE-SICS/PCIOL 
3. Sivagamy 70/F 382947 BE–IMC L>R LE-SICS/PCIOL 
4. Rubavathy 60/F 390756 BE–IMC R>L RE-SICS/PCIOL 
5. Gopal                42/M 391787 BE-IMC R>L RE-SICS/PCIOL 
6. Krishnan 70/M 393782 LE- PHACOLYTIC 
GL 
RE-SICS/PCIOL 
7. Savithri 58/F 390999 BE–IMC R>L RE-SICS/PCIOL 
8. Selvaraj 59/M 396179 LE –IMC LE-SICS/PCIOL 
9. Elumalai 65/M 399979 RE –IMC LR-PCIOL RE-SICS/PCIOL 
10. Narayanan 70/M 392147 LE –IMC LE–SICS/PCIOL 
11. Velusamy 52/M 392436 BE–IMC L>R RE–SICS/PCIOL 
12. Syed Nazar 65/M 399423 BE-IMC L>R LE–SICS/PCIOL 
13. Gowri 52/F 399415 LE -MC RE-PCIOL LE–SICS/PCIOL 
14. John 68/M 399442 BE-IMC R>L RE–SICS/PCIOL 
15. Ayisha Bee 55/F 399961 BE-IMC R>L RE–SICS/PCIOL 
16. Devi 65/F 400200 RE –IMC RE–PHACO/PCIOL 
17. Ananthraman 58/M 400474 RE –IMC RE–PHACO/PCIOL 
18. Indrani 52/F 400576 RE –IMC RE–PHACO/PCIOL 
19. Muniammal 60/F 394493 RE-FUNGAL 
CORNEAL ULCER 
WITH HYPOPYON 
RE-TKP 9MM OVER 8MM 
20. Ravi 17/M 25789 LE CHALAZION LE – I & C 
21. Kaveri 37/F 27240 RE-PTERYGIUM EXCISION 
22. Rajammal 35/F 384392 LE-FUNGAL 
CORNEAL ULCER 
WITH HYPOPYON 
LE – AC WASH WITH AMP 
– B 
23. Muniappan 59/M 83120 LE-PAN 
OPHTHALMITIS 
LE-EVISCERATION 
24. Shanthi 52/F 376292 RE-ABSOLUTE 
GLAUCOMA 
RE-CYCLOCRYO 
25. Lakshmi 50/F 396830 RE-CHR. 
DACROCYSTITIS 
RE DCR 
26. Babu 09/M 396857 RE-TRAUMATIC 
ENDOPHTHALMITIS
RE-INTRA VITREAL 
INJECTION OF BROAD 
SPECTRUM  ANTBIOTICS 
27. Malakondiah 55/M 387906 BE-SEC ACG RECOMBINED SUR 
28. Girija 45/F 402574 BE-PACG RE-AG SURGERY 
29. Shankar 32/M 402574 RE-CHR. 
DACROCYSTITIS 
RE – DCR 
30. Jaibunisa 15/F 397265 RE-OLD RHEG.RD RE-RD SURG (360º 
ENCIRCLAGE WITH 
CRYO WITH SRF 
DRAINAGE) 
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RIGHT SIXTH NERVE PALSY 
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LATERAL VIEW OF THE COURSE OF THIRD NERVE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOCATION OF PUPILLOMOTOR FIBRES WITHIN  
`THE TRUNK OF THE THIRD NERVE  
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TROCHLEAR NERVE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DORSAL VIEW OF THE COURSE OF  
TROCHLEAR NERVE 
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LATERAL VIEW OF THE COURSE OF SIXTH NERVE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LOCATION OF THE CRANIAL NERVES IN THE  
CAVERNOUS SINUS VIEWED FROM BEHIND 
 
 
 
 
 
 
 
 
S.No Name Age Sex Laterality Complaints FBS PPBS Fundus III N VI  N Urine Alb Recovery HbA1c
1 Durai 55 M LE Diplopia 128 165 NAD N P N Full 6.5
2 Rajalakshmi 48 F LE Diplopia 152 212 HTR N P N Full 7.5
3 Ramachandran 54 M LE Diplopia 100 180 NAD N P N Full 7
4 Krishnan 50 M RE Diplopia 132 198 NAD N P N Lost 8
5 Jayamma 60 F LE Drooping 180 270 ModNPDR P N P Full 10.5
6 Rani 55 F LE Drooping 112 224 NAD P N N Partial 9.5
7 Aftab 50 M LE Drooping 145 202 ModNPDR P P P Partial 9
8 Chinnaiya 53 M LE Diplopia 130 165 POST PRP N P P Full 7.5
9 Indrani 60 F RE Diplopia 98 137 NAD N P N Full 6.5
10 Naduman bee 45 F LE Diplopia 136 168 NAD N P N Full 6.7
11 Chandrasekar 70 M RE Diplopia 111 214 NAD N P N Lost 6
12 Pandurangan 66 M LE Diplopia 144 200 Mild NPDR N P P Partial 7.5
13 Meenakshi sundaram 58 M RE Diplopia 106 152 NAD N P N Full 5.8
14 Vanaja 54 F LE Diplopia 178 252 ModNPDR N P N Partial 9
15 Christie raj 56 M LE Drooping 125 186 Mild NPDR P N N Lost 8.5
16 Kuppammal 44 F RE Drooping 212 380 ModNPDR P N P Full 10
17 Ester 53 F RE Drooping 102 156 NAD P N N Full 6.2
18 Sundarajan 48 M LE Diplopia 143 198 ModNPDR N P N Full 7
19 Natarajan 52 M RE Diplopia 322 486 Mild NPDR N P P No recovery 11
20 Sokkanayaki 65 F RE Drooping 80 136 Mild NPDR P N N Lost 5.5
21 Meenakshi 62 F LE Drooping 129 211 Mild NPDR P N N Full 7
22 Jayalakshmi 52 F RE Drooping 165 254 NAD P N N Full 8
23 Arunachalam 65 M LE Diplopia 145 206 Mild NPDR N P N Full 7.8
24 Lakshmi 23 F RE Diplopia 68 110 NAD N P N Full 6
25 Gopinath 57 M LE Diplopia 154 222 HTR N P N Full 8
MASTER CHART
26 Rupalingam 56 M RE Drooping 118 162 Mild NPDR P N N Full 8.5
27 Rajammal 60 F LE Drooping 200 296 NAD P N N Lost 9
28 Saraswathi 54 F LE Drooping 123 173 HTR P N N Full 7
29 Krishnachari 50 M LE Diplopia 177 256 NAD N P N Full 7.5
30 Kathamuthu 58 M RE Drooping 188 303 NAD P N N Full 8
31 Gopalakrishnan 66 M LE Drooping 218 342 NAD P N N No recovery 9
32 Meena 38 F RE Drooping 175 282 Mild NPDR P N N Full 9.5
33 Muthusamy 55 M LE Diplopia 144 228 NAD N P N Full 8.4
34 Vijaya 58 F LE Diplopia 118 192 NAD N P P Full 6.5
35 Kala 38 F RE Diplopia 106 168 NAD N P N Full 6
36 Chokalingam 56 M LE Drooping 212 200 NAD P N N Partial 8.5
37 Gopinath 35 M RE Diplopia 162 241 NAD N P N No recovery 7.5
38 Elumalai 70 M LE Drooping 149 193 NAD P N N Lost 6.5
39 Ananad 55 M LE Diplopia 176 242 Mild NPDR N P N Full 7.5
40 Balamani 57 F RE Diplopia 128 175 ModNPDR N P N Partial 8.5
41 Thangarajan 60 M RE Diplopia 147 204 Mild NPDR N P N Partial 9
42 Nagammal 39 F RE Diplopia 120 189 NAD N P N Full 7
43 Panchatcharam 65 M LE Diplopia 228 375 NAD N P N Partial 10
44 Kamala 57 F LE Drooping 147 290 Mild NPDR P N N Partial 7.5
45 Rajasekar 54 M LE Diplopia 125 249 NAD N P N Lost 8.5
46 Sokkammal 58 F RE Diplopia 78 118 ModNPDR N P N Partial 7.5
47 Malakondaiah 60 M LE Drooping 101 187 Noview P N N Full 6.5
48 Vanaja 45 F LE Diplopia 197 286 NAD N P N Full 7
49 Nagapoornam 55 M LE Diplopia 129 170 NAD N P N Full 8
50 Mouiden 55 M RE Diplopia 112 137 ModNPDR N p P Partial 6
51 Ibrahim 50 M LE Diplopia 206 311 NAD N P N Full 9.5
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GLYCAEMIC CONTROL AND MICRO VASCULAR 
COMPLICATIONS IN VI NERVE PALSY 
VI Nerve Urine – Alb Retinopathy
